搜尋結果
Biogen to Pay Up to $1.8 Billion for Immune Drug Developer
Bloomberg· 2 日前Have a confidential tip for our reporters? Biogen Inc. agreed to acquire Human Immunology ...
Cubans put Asian silkworms to work for artisans in experimental project
Reuters· 2 日前Martin, who heads the ArteSeda project at the "Indio Hatuey Experimental Station" in ...
Weight-Loss Upstart Viking Needs a Deal to Vie With Lilly and Novo
Bloomberg· 2 日前Hope for a weight-loss drug that’s better than Ozempic and Wegovy has sent Viking Therapeutics ...
Council Post: Lead Generation Reimagined: Strategic Insights For Purpose-Driven Entrepreneurs
Forbes· 3 日前Navigating the complexities of lead generation is a common hurdle for all entrepreneurs. The ...
Up 165% This Year, Will Dyne Therapeutics Continue Its Stellar Run?
Forbes· 3 日前: DYN), a biotechnology company focused on advancing genetically driven muscle diseases ...
Why Boeing Needs A New Plane — Soon
Forbes· 3 日前With its best-selling plane, the 737 Max, the subject of public and federal scrutiny after the ...
Why Boeing Needs A New Plane — Soon
Forbes· 3 日前With its best-selling plane, the 737 Max, the subject of public and federal scrutiny after the ...
Healthy Returns: Eli Lilly, Novo Nordisk are competing to develop more convenient weekly insulins
CNBC· 3 日前A patient injects herself with an insulin pen. The rivalry between Eli Lilly and Novo Nordisk ...
Spotify's 'Listening Party' feature falls short of expectations
TechCrunch· 3 日前It’s been three years since Spotify acquired live audio startup Betty Labs, and yet the music ...
US FDA staff says Guardant's test may fail to detect some pre-cancerous tumors
Reuters· 3 日前, opens new tab experimental blood test for a cancer of colon or rectum may fail to detect some ...